Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price30.36 USD
Fair value30.00
Ethical score70.0/100
Our investment reviews on this name
2026-07-02Read Accumulation30.28+0.3% to today ✓First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Sila Realty Trust, Inc. holds its Accumulation at $30.36. Consolidating, no directional conviction, held for 7 days.
As held on the ledger · 2026-08-27
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 7 days
Price at the screen
$30.36
Valuation
44.65 trailing · N/A forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.33
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
34.15%
Below 33%
Interest-bearing debt is 34.1% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
4.85%
Below 49%
Money owed to the company is 4.9% of assets, under the 49% limit.
Pass
Revenue purity
0.59%
Below 5%
Only 0.6% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Sila Realty Trust,'s business is in a permissible area, but its interest-bearing debt is about 34% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when SILA's ethical verdict changes
Today SILA does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-08-27 screen. The gold marker is the market price at the same screen. The price runs 1.2% above the base estimate.
Third-party analyst targets: 4 covering, consensus Hold. The average target sits −1% from the screen price.
Reading the gap · Our model and the Street both land near the screened price: fairly valued, with no strong edge either way.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Healthcare Landlord Delivers Thin Returns at Best
Picture a landlord who signs long leases with hospitals and clinics, expecting steady rents that never miss. Sila Realty Trust does exactly that in the US healthcare space, posting 9% revenue growth and a 19% profit margin. Yet the business earns just 3% on equity, and the shares sit a touch above our fair value with no margin of safety left.
The market already prices the stock at the analysts' $30 median target, and the opportunity rating sits at none. A clean ethical screen is welcome, but it does not create an edge when returns on capital stay this low and growth fails to lift profitability.
Interest-rate moves and tenant concentration remain real risks for any net-lease REIT, even in resilient healthcare. Without stronger returns or a clearer discount, the setup offers little reason to step in. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
SILA trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-22Accumulation$30.36+0.0%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it hold, with a mean price target of $30.
2026-10-02Accumulation$30.36+0.0%Entry 6
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it hold, with a mean price target of $30.
2026-09-12Accumulation$30.36+0.0%Entry 5
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it hold, with a mean price target of $30.
2026-08-12Accumulation$30.36+0.3%Entry 4
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it hold, with a mean price target of $30.
2026-07-18Accumulation$30.28+0.0%Entry 3
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it hold, with a mean price target of $30.
2026-07-03Accumulation$30.28+0.0%Entry 2
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Accumulation$30.28Entry 1
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
